Molecule intelOpportunity: Lower0Crowded market

Piroxicam

243 brands · 176 companies · product forms

1 DRAP alert

Opportunity snapshot

Launch attractiveness
24
Market saturation
100
Price room
100
Regulatory risk
50
243
brands
176
companies
Rs 357
median price
26
price points
17.92x
price spread
90
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 2%

Price room

Across observed sources and strengths
CheapestRs 46.48
MedianRs 357
Most expensiveRs 832.8
Spread17.92×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 17.92x across 26 trusted points (Rs 46.48-832.8). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Piroxicam — each links to its own medicine page.

Regulatory alerts

Safety exposurelatest 2026-06-02
31. Rapid Alert – SPURIOUS / FALSIFIED BREXIN TABLETS 20 mg

Why this score

Launch attractiveness

40% supply-gap(0) + 25% price-variation(100) + 20% low-competition(0) + 15% supply-disruption(0), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

176 canonical companies and 243 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 17.92x across 26 trusted points (Rs 46.48-832.8). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

1 DRAP alert(s), latest 2026-06-02 incl. recall/safety.

Confidence

Reduced by: no ATC code.

Packaged brief for this lower opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.